Alliance Global Partners Initiates a Buy Rating on CNS Pharmaceuticals (CNSP)
In a report released today, James Molloy from Alliance Global Partners initiated coverage with a Buy rating on CNS Pharmaceuticals (CNSP – ...
CNS Pharmaceuticals initiated with a Buy at Alliance Global Partners
Alliance Global Partners initiated coverage of CNS Pharmaceuticals (CNSP) with a Buy rating and $4 price target CNS is a clinical-stage ...